At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MRNY YieldMax MRNA Option Income Strategy ETF
Trading 08-07 15:39:13 EDT
15.07
+0.85
+5.94%
High15.24Low14.38Vol107.79K
Open14.38D1 Closing14.22Amplitude6.05%
Mkt Cap112.69MTradable Cap112.69MTotal Shares7.48M
T/O1.60MT/O Rate1.44%Tradable Shares7.48M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Soligenix Q2 Net Loss Narrows as R&D Expenses Fall
Reuters  ·  08-07 19:39
Soligenix Q2 Net Loss Narrows as R&D Expenses Fall
Moderna Inc. Stock Sheds 4.3%, Underperforms Peers
Dow Jones  ·  08-07 04:35
Moderna Inc. Stock Sheds 4.3%, Underperforms Peers
Arcturus Q2 Revenue Falls Sharply on CSL Seqirus Deal End
Reuters  ·  08-07 04:12
Arcturus Q2 Revenue Falls Sharply on CSL Seqirus Deal End
Moderna Stock Slips Despite FDA Approval for New Flu Shot mFlusiva
TIPRANKS  ·  08-06 23:37
Moderna Stock Slips Despite FDA Approval for New Flu Shot mFlusiva
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)
TIPRANKS  ·  08-06 23:10
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)
Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future
Dow Jones  ·  08-06 20:26
Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future
Pre-Market Outlook: US Index Futures Mixed; Memory Chip Stocks Slide on SanDisk and Western Digital Guidance Miss
Stock News  ·  08-06 20:08
Pre-Market Outlook: US Index Futures Mixed; Memory Chip Stocks Slide on SanDisk and Western Digital Guidance Miss
Novavax Lifts Annual Revenue Forecast as Licensing Bets Offset Weak Vaccine Demand
Reuters  ·  08-06 20:00
Novavax Lifts Annual Revenue Forecast as Licensing Bets Offset Weak Vaccine Demand
U.S. Stocks on the MOVE-Cheniere Energy, TPG, Constellation Energy
Reuters  ·  08-06 19:42
U.S. Stocks on the MOVE-Cheniere Energy, TPG, Constellation Energy
Roivant Q1 FY27 Net Loss Widens to $290.61 Million; Revenue Slips to $1.44 Million
Reuters  ·  08-06 19:07
Roivant Q1 FY27 Net Loss Widens to $290.61 Million; Revenue Slips to $1.44 Million
Sandisk, AppLovin, Moderna, and More Stocks That Explain Today's Market
Dow Jones  ·  08-06 18:42
Sandisk, AppLovin, Moderna, and More Stocks That Explain Today's Market
Moderna Shares up 4% Premarket After US FDA Approval for Flu Vaccine
THOMSON REUTERS  ·  08-06 18:37
Moderna Shares up 4% Premarket After US FDA Approval for Flu Vaccine
Moderna Secures FDA Approval for First mRNA Flu Vaccine After Regulatory Hurdles, Commercial Prospects Remain Uncertain
Stock News  ·  08-06 14:30
Moderna Secures FDA Approval for First mRNA Flu Vaccine After Regulatory Hurdles, Commercial Prospects Remain Uncertain
PRESS Digest -Wall Street Journal - August 6
Reuters  ·  08-06 13:36
PRESS Digest -Wall Street Journal - August 6
PRESS Digest-New York Times Business News - August 6
Reuters  ·  08-06 13:19
PRESS Digest-New York Times Business News - August 6
US FDA Approves First mRNA Flu Shot from Moderna
Reuters  ·  08-06 10:17
US FDA Approves First mRNA Flu Shot from Moderna
Moderna: Gets U.S. FDA Approval for Influenza Vaccine Mflusiva for Use in Adults 50 Years and Older
THOMSON REUTERS  ·  08-06 10:15
Moderna: Gets U.S. FDA Approval for Influenza Vaccine Mflusiva for Use in Adults 50 Years and Older
Moderna: Expects Supply of Influenza Vaccine Mflusiva to be Available in Select Retailers in Coming Weeks
THOMSON REUTERS  ·  08-06 10:15
Moderna: Expects Supply of Influenza Vaccine Mflusiva to be Available in Select Retailers in Coming Weeks
Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1
TIPRANKS  ·  08-06 07:25
Takeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1
Moderna Shingles Vaccine Trial Terminated: What It Means for MRNA Investors
TIPRANKS  ·  08-06 00:30
Moderna Shingles Vaccine Trial Terminated: What It Means for MRNA Investors

Introduction

Company Name.
YieldMax MRNA Option Income Strategy ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund advisor will seek to employ the fund's investment strategy as the fund relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. The fund is non-diversified.
Issue price:
--